Patents by Inventor Lia Suzanne Rotherham

Lia Suzanne Rotherham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis of tuberculosis
    Patent number: 9176134
    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homologous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: November 3, 2015
    Assignee: CSIR
    Inventors: Lia Suzanne Rotherham, Makobetse Abel Khati, Matsopiane Charlotte Maserumule
  • DIAGNOSIS OF TUBERCULOSIS
    Publication number: 20150260716
    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homogolous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Inventors: Lia Suzanne Rotherham, Makobetse Abel Khati, Matsopiane Charlotte Maserumule
  • DIAGNOSIS OF TUBERCULOSIS
    Publication number: 20140370516
    Abstract: The invention comprises an oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6. The invention also comprises a complementary oligonucleotide of the oligonucleotide selected from the group comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6, an oligonucleotide being at least 80% homologous thereto, a truncated portion of any of the aforementioned, or a pairing of any of the aforementioned.
    Type: Application
    Filed: September 21, 2012
    Publication date: December 18, 2014
    Applicant: CSIR
    Inventors: Lia Suzanne Rotherham, Makobetse Abel Khati, Matsopiane Charlotte Maserumule